Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SILVER dose-finding trial of silymarin for drug-induced elevated liver enzymes
2020-004645-36Phase 2Completed
- Sponsor
- Fraunhofer-Gesellschaft
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of silymarin in Drug-induced hepatitis (DILI) and elevated alanine aminotransferase (4 arms), sponsored by Fraunhofer-Gesellschaft. Started Mar 2021; status: completed.
02
Drugs
silymarin
03
Conditions
Drug-induced hepatitis (DILI)elevated alanine aminotransferase
Beyond the preview
Go deeper on 2020-004645-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004645-36.